CELLTRION

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.
CELLTRION
Industry:
Biotechnology Health Care Manufacturing
Founded:
2002-02-01
Address:
Incheon, Inch'on-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.celltrion.com
Total Employee:
1001+
Status:
Active
Contact:
+82328505000
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Albatha
Albatha is an investment holding with investments & development in the automotive, healthcare, manufacturing, food, & electronics sectors.
Atrium Medical
Atrium Medical Corporation, a healthcare company, engages in the research and development, design, and manufacture of medical device
Beike Biotechnology
Beike is the stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
CK Life Sciences International
CK Life Sciences International is engaged in the business of research and development, manufacturing, commercialisation, marketing, sale of.
GABA International
GABA International is engaged in the research, development, manufacture, and marketing of oral care products.
Jianlaifu
Jianlaifu engages in health food research and development, contract manufacturing, and sales operations.
Naturalendo Tech
Naturalendo Tech is engaged in the research and development and manufacture of hormone products
Pharming Group
Pharming Group is a developer and manufacturer of human therapeutic proteins.
Polymate
Polymate Ltd is a research facility that develops hybrid polyurethane materials and fire protective coatings.
ReproCELL
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies.
Sanofi
Sanofi is engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions.
Sinocare
Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing.
T-mab BioPharma
T-mab BioPharma is specializing in the research and development and production of genetically engineered drugs
Yunnan Botanee Bio Technology Group
Yunnan Bethany Biotechnology manufactures and markets skin care products.
Current Employees Featured
SeungSuh Hong SVP, Business Development @ Celltrion
SVP, Business Development
Jung Jin Seo Founder @ Celltrion
Founder
Founder
Stock Details
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-06-07 | Iksuda Therapeutics | Celltrion investment in Series A - Iksuda Therapeutics | 47 M USD |
Official Site Inspections
http://www.celltrion.com Semrush global rank: 1.07 M Semrush visits lastest month: 31.23 K
- Host name: 52.252.23.178
- IP address: 52.252.23.178
- Location: Boydton United States
- Latitude: 36.6534
- Longitude: -78.375
- Metro Code: 560
- Timezone: America/New_York
- Postal: 23917

More informations about "Celltrion"
셀트리온 Celltrion
Celltrion's R&D personnel with masters and doctoral degrees account for around 33% of total employees. At the Global R&D Center, our R&D specialists are striving to develop new …See details»
Celltrion Healthcare
Celltrion Healthcare will shape a healthier and happier future for humanity by offering high-quality biologics. Celltrion Healthcare offers biologics to about 110 countries, along with more than 30 global partners around the world. With …See details»
Celltrion - Wikipedia
Celltrion, Inc. (Korean: 주식회사 셀트리온) is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. See details»
Celltrion - Crunchbase Company Profile & Funding
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly …See details»
셀트리온 Celltrion
Mar 25, 2025 Celltrion Receives EC Approval for Avtozma® (CT-P47), a Biosimilar to RoActemra® (tocilizumab) ... regardless of whether drug tariffs are imposed.Production through …See details»
Where's Crohn's and Colitis?
In 2023, Celltrion partnered with the European Federation of Crohn’s & Ulcerative Colitis Associations (EFCCA) for World IBD Day to spotlight age-based inequalities in IBD in the first …See details»
Celltrion to Break Ground on CDMO Plant in 2025
Dec 12, 2024 Celltrion, a leading South Korean biosimilar developer, has announced plans to enter the CDMO market, investing 1.5 trillion won (USD 1 bn) to construct a 200,000-liter …See details»
Celltrion Healthcare Co.,Ltd. - The Org
Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion …See details»
Celltrion Group Launches Celltrion BioSolutions to Enter CDMO …
Dec 17, 2024 Celltrion Group Chairman Seo Jung-jin has announced the establishment of Celltrion BioSolutions, a new company specializing in contract development and …See details»
Celltrion to break ground on CDMO plant in 2025: …
Nov 28, 2024 South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (CDMO) plant in Korea next year, said its chairman about three months after the …See details»
Celltrion - Overview, News & Similar companies | ZoomInfo.com
Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EC's approval for Inflectra® and …See details»
Celltrion CONNECT
The Celltrion CONNECT Patient Support Program provides ongoing support to patients prescribed a Celltrion medication. Select your prescribed medication to learn more:See details»
셀트리온 Celltrion
The cornerstone of Celltrion's global biotechnology leadership is its Global R&D Center, where cutting-edge biosimilars and novel drug modalities are brought to life. Leveraging a wealth of …See details»
Celltrion BioSolutions launched to venture into CDMO
Dec 17, 2024 Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDMO market. As a newcomer …See details»
Celltrion Group Chairman Seo Jeong-jin (photo), who leads the ...
14 hours ago Celltrion is also supporting ventures by creating funds at the group level. Chairman Suh proposed to launch a "national work movement" to reboot the Korean economy, which is …See details»
Celltrion Inc Company Profile - Celltrion Inc Overview - GlobalData
Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on the research, development, and manufacture of biosimilars and novel biopharmaceuticals. The company …See details»
Celltrion Healthcare
Celltrion is a combination of the terms “cell” in our body and “Triones,” a guiding star that is also known as the Big Dipper. The name of our company conveys our will to promote the health …See details»
Celltrion Online Brochure
Celltrion is a trusted partner with a proven track record, boasting 2,100+ successful cGMP DS batches and a 98.5% batch success rate. With over 400 regulatory approvals in 90+ countries, …See details»
셀트리온 Celltrion
Celltrion Inc. & Celltrion Healthcare Co., Ltd. merger completed Oct. 2023 Remsima SC (US product name:Zymfentra) received approval by US FDA as novel therapeuticsSee details»
Seo Jung-jin (businessman) - Wikipedia
Seo has two sons. His first son, Seo Jin-seok (서진석), is chairman of the board at Celltrion and Celltrion Pharm.His second son, Seo Jun-suk (서준석), is Celltrion Healthcare's chairman of …See details»